News
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement ...
The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.
In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...
FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...
The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...
The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...
Moderna's mNexspike COVID vaccine approved by FDA for older adults and at-risk groups after Phase 3 trial shows improved ...
Despite uncertainties arising from new FDA policies around COVID-19 vaccines, Moderna has cleared the agency's desk with its ...
The Food and Drug Administration (FDA) just green-lit a new Covid vaccine from Moderna, the company said in a press release ...
The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...
The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results